Effects of Replacing Diet Beverages With Water on Weight Loss and Plasma Glucose Control in Type 2 Diabetes
Study Details
Study Description
Brief Summary
The purpose of the present study is to evaluate the effect of replacing diet beverages with water on weight loss and biochemical indicators for insulin sensitivity and cardiometabolic risk factors of diabetic obese and overweight female adults when they are in a multidisciplinary weight loss plan.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Diet Beverages (DBs) Diet beverages after the main meal+ Diet |
Behavioral: DBs at the end of the main meal + Diet
Subjects are asked to have 250 ml DBs at the end of their lunch as the main meal, while they are on a multidisciplinary diet plan for 24 weeks.
|
Experimental: Water Water after the main meal+ Diet |
Behavioral: Water at the end of the main meal+ Diet
Subjects are asked to have 250 ml water at the end of their lunch as the main meal, while they are on a multidisciplinary diet plan for 24 weeks.
|
Outcome Measures
Primary Outcome Measures
- Weight loss [24 weeks]
Secondary Outcome Measures
- Fasting plasma glucose [24 weeks]
- Insulin resistance (HOMA) [24 weeks]
- Lipid profiles [24 weeks]
- Waist circumference [24 weeks]
- BMI [24 Weeks]
- HA1C [24 Weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diabetic female patient with 6.5<H1AC<7.2.
-
Monotherapy with Metformin.
-
18-45 years of age.
-
Body mass index (BMI) between 27-35 kg/ m².
-
Consume DBs regularly during their habitual diet.
-
Must be able to have moderate exercise.
-
Must be interested to have weight loss.
Exclusion Criteria:
-
Participating in a research project involving weight loss or physical activity in the previous six months.
-
Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next six months.
-
Taking medication that could affect metabolism or change body weight.
-
Report heart problems, chest pain, and cancer within the last five years.
-
Unwilling to change intake of beverages during the study period.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | NovinDiet Clinic | Tehran | Iran, Islamic Republic of | 1913635136 |
Sponsors and Collaborators
- Novindiet Clinic
- University of Nottingham
- Tehran University of Medical Sciences
Investigators
- Study Chair: Hamid R Farshchi, MD, PhD, NovinDiet Clinic, School of Life Sciences, The University of Nottingham
- Principal Investigator: Ameneh Madjd, Dr, NovinDiet Clinic, School of Life Sciences, The University of Nottingham
- Principal Investigator: Ian A Macdonald, Prof., School of Life Sciences, The University of Nottingham
- Principal Investigator: Moira A Taylor, PhD, School of Life Sciences, The University of Nottingham
- Principal Investigator: Reza Malekzadeh, Prof., Digestive Disease Research Institute, Tehran University of Medical Sciences
- Principal Investigator: Alireza Delavari, MD, Digestive Disease Research Institute, Tehran University of Medical Sciences
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ND-107